BioSpace News Archive

Following the successful launch of its patent-protected CBD-BCP soft gel formulation, the company has demonstrated its focus on consumer safety in an area many others are failing.

Inovio Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2019.

PDL BioPharma, Inc. reports financial results for the three months ended March 31, 2019

Deciphera Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2019 and provided an update on clinical and corporate developments.

ProtoKinetix, Incorporated is announcing that the Company has secured a partnership agreement with IMPART investigator team Canada at Dalhousie University and has now commenced studies to reveal the benefits of PKX-001 in cardiac metabolism.

Financial Matters Expert to Serve as Chair of Audit Committee

Results from independent actuarial review validate significant claims savings within one year, and sustained results over five years

Vivimed Life Sciences Pvt Ltd (Vivimed) is recalling 19 lots of Losartan Potassium Tablets USP 25 mg, 50 mg, and 100 mg to consumer level due to the detection of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), a possible process impurity or contaminant in an active pharmaceutical ingredient manufactured by Hetero Labs Limited (API manufacturer), that is above the US Food & Drug Administration’s interim acceptable exposure limit of 9.82 ppm.

The Avoca Group announced today that David Shing, Verizon Media’s Digital Prophet, will deliver the keynote address at the 8th Annual Avoca Global Summit.

Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education, will present the 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®. The conference will take place Nov. 6-8 at the New York Marriott Marquis in New York City.